Modulation of Colorectal Tumor Behavior via lncRNA TP53TG1-Lipidic Nanosystem
Long non-coding RNAs (lncRNAs) are an emerging group of RNAs with a crucial role in cancer pathogenesis. In gastrointestinal cancers, TP53 target 1 (TP53TG1) is an epigenetically regulated lncRNA that represents a promising therapeutic target due to its tumor suppressor properties regulating the p53...
Saved in:
Main Authors: | Farimah Masoumi (Author), Sofia M. Saraiva (Author), Belén L. Bouzo (Author), Rafael López-López (Author), Manel Esteller (Author), Ángel Díaz-Lagares (Author), María de la Fuente (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics
by: Surasa Nagachinta, et al.
Published: (2020) -
Mutation analysis of TP53 in colorectal cancer, Peshawar, Khyber Pakhtunkhwa, Pakistan.
by: Mian Adnan Kakakhel, et al.
Published: (2021) -
LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
by: Rui Huang, et al.
Published: (2020) -
lncRNA ZEB1-AS1 Was Suppressed by p53 for Renal Fibrosis in Diabetic Nephropathy
by: Juan Wang, et al.
Published: (2018) -
Predictive significance of glycolysis-associated lncRNA profiles in colorectal cancer progression
by: Rui Mao, et al.
Published: (2024)